Chase Medical Research, LLC   Report issue

For profit Phase 3
Founded: Waterbury CT United States (2006)

Organization Overview

First Clinical Trial
2010
NCT01101841
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Chase Medical Research, LLC, Waterbury, CT 06708

Active Ingredients

Drugs in Phase 3 Trials (1)

paroxetine (paxil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hot Flashes (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1